News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Groups Urge FDA To Halt Launch Of Zogenix, Inc. (ZGNX)'s Zohydro Pain Drug



2/28/2014 7:37:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

(Reuters) - A coalition of addiction experts, physicians and others is urging U.S. health officials to reverse course and block the launch of a powerful painkiller called Zohydro, expected to hit the market next month.

The opioid drug, manufactured by Zogenix Inc, contains a potent amount of an active ingredient that could be lethal to new patients and children and is not safer than other current pain drugs, the groups told the Food and Drug Administration.

Hey, check out all the research scientist jobs. Post your resume today!

Read at News Release
Read at Reuters
Read at Forbes
Read at CNN
Read at NBC


comments powered by Disqus
News Release
Reuters
Forbes
CNN
NBC
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES